A totally recombinant fibrin matrix for mesenchymal stem cell culture and delivery
- 28 August 2018
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 106 (12) , 3135-3142
Abstract
Mesenchymal stem cells (MSCs) have been widely studied for tissue engineering and treating diseases in laboratories, clinical trials, and clinics. Fibrin matrices are often used to culture MSCs or increase the retention of MSCs at the injection site. However, fibrins made with the human plasma derived fibrinogen have high cost and risk of human pathogen transmission. In this article, we studied if fibrin matrices made with recombinant human fibrinogen, recombinant human thrombin, and recombinant human factor XIII could be used to culture and deliver MSCs. We systematically investigated the relationships between the fibrin matrix formulation, its nanostructure, and the behaviors of the cells in the matrix including the cell morphology, viability, and growth. We found that the fibrinogen concentration significantly affected the matrix structure and cell behaviors. We then used an optimized fibrin matrix to deliver human MSCs into mice subcutaneously. We found that the matrix could significantly enhance the retention of MSCs at the injection site. To our best knowledge, this is the first study on using fibrin matrices made with entirely recombinant proteins for culturing and delivering MSCs. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2018.Keywords
Funding Information
- U.S. Department of War (W81XWH‐BAA‐11‐1 ERMS No.10091006)
This publication has 44 references indexed in Scilit:
- The spreading, migration and proliferation of mouse mesenchymal stem cells cultured inside hyaluronic acid hydrogelsBiomaterials, 2011
- DNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cellsBiomaterials, 2009
- A fibrinogen-based precision microporous scaffold for tissue engineeringBiomaterials, 2007
- Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingStem Cells, 2007
- Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiationBMC Genomics, 2007
- Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/ scid miceProceedings of the National Academy of Sciences, 2006
- Regulation of Proliferation and Chondrogenic Differentiation of Human Mesenchymal Stem Cells by Laminin‐5 (Laminin‐332)Stem Cells, 2006
- Autologous mesenchymal stem cell transplantation in stroke patientsAnnals of Neurology, 2005
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991